Quantitative real-time PCR was utilized to evaluate retrovilated with biologic titers performed on the test material. The ral vector titer. RNA was prepared from vector supernatant 96-well capacity of the machine and 2 h of running time and run in a one-step RT-PCR reaction combining reverse permit titer determinations within 8 h, facilitating the protranscription (RT) and amplification in one tube. Recent concern about the immunogenic potential of these gene products in animals models and human clinical trials have prompted investigators to remove drug selection genes from vector constructs. 6,7 To simplify titer determination, and facilitate rapid identification of hightiter producer clones, investigators have utilized PCR and RNA dot blot assays to estimate vector RNA in supernatant preparations. [8] [9] [10] These methods are helpful in separating vectors with large to modest differences in titer but remain semi-quantitative. The development of real-time PCR technology, which combines PCR and fluorescence detection of target sequences, may provide a method for quantitative PCR with increased accuracy over current methods. 11, 12 In addition, this technology provides for processing of large number of samples (96 reactions per run), one-step RT-PCR reactions (reverse transcription and PCR amplification in one tube), and real-time read-out (without the need for electrophoresis or dot blot analysis). This article demonstrates how this methodology accurately predicts biologic titers, significantly decreases turn around time, and decreases technician time. It has greatly simplified the screening of vector producer cells for high titer clones.
Estimation of retroviral vector titer and identification of high-titer packaging cell lines have been aided by the incorporation of selectable markers within the vector genome. These markers have typically been drug selection genes [1] [2] [3] [4] or molecules expressed on the cell surface. 5 Recent concern about the immunogenic potential of these gene products in animals models and human clinical trials have prompted investigators to remove drug selection genes from vector constructs. 6, 7 To simplify titer determination, and facilitate rapid identification of hightiter producer clones, investigators have utilized PCR and RNA dot blot assays to estimate vector RNA in supernatant preparations. [8] [9] [10] These methods are helpful in separating vectors with large to modest differences in titer but remain semi-quantitative. The development of real-time PCR technology, which combines PCR and fluorescence detection of target sequences, may provide a method for quantitative PCR with increased accuracy over current methods. 11, 12 In addition, this technology provides for processing of large number of samples (96 reactions per run), one-step RT-PCR reactions (reverse transcription and PCR amplification in one tube), and real-time read-out (without the need for electrophoresis or dot blot analysis). This article demonstrates how this methodology accurately predicts biologic titers, significantly decreases turn around time, and decreases technician time. It has greatly simplified the screening of vector producer cells for high titer clones.
Real-time PCR was performed using the ABI Prism 7700 Sequence Detector (TaqMan; PE Applied Biosystems, Foster City, CA, USA) which combines PCR tech-nology with fluorescence detection. The machine contains a 96-well PCR block and each well has a fluorescence detector which can monitor emissions within individual wells. The PCR reaction differs from standard PCR by relying on the 5Ј-3Ј nuclease activity of AmpliTaq Gold (PE Biosystems) and the inclusion of a TaqMan probe. The TaqMan probe contains a fluorescent reporter and a quencher molecule. During PCR, the AmpliTaq Gold polymerase cleaves the reporter molecule from the annealed probe and the level of fluorescence detected by the machine directly correlates with the amount of target DNA being amplified. More specifically, the cycle in which fluorescence rises above the threshold level correlates with the amount of target DNA in the test material.
In developing a protocol for quantifying vector titer, primers for the neomycin phosphotransferase gene (neo) were evaluated so that a direct comparison of real-time PCR and a biologic titer method could be performed. For real-time PCR analysis, RNA isolation was modified from the methods of Murdoch et al, 8 in which 300 l of cellfree supernate (0.45 filtered) was added to a mixture of 900 l of TriPure Reagent (Roche, Indianapolis, IN, USA) with 10 g of carrier RNA (yeast tRNA; Roche) and 240 l of chloroform. The mixture was vortexed for 30 s, incubated at room temperature for 10 min, then spun at 10 000 r.p.m. in an Eppendorf centrifuge for 10 min. The aqueous layer was isolated and RNA precipitated with 600 l of isopropanol. The dried pellet was resuspended in 100 l of RNAse-free water. Ten microliters of the suspension were added to a one-step RT-PCR reaction (both reverse transcription and amplification are performed per TaqMan Gold PCR Kit; PE Applied Biosystems). The 50 l total reaction volume consisted of 300 nm each of forward and reverse primer, 100 nm probe, 300 m each dNTP, 5.5 mm MgCl 2 , 0.025 units/l AmpliTaq Gold, 0.25 unit/l multiscribe reverse transcriptase, 0.4 unit/l RNase inhibitor, 1× TaqMan Buffer A, template, and RNase-free water to volume. Amplification was performed using one cycle of 48°C for 30 min, one cycle of 95°C for 10 min, and 40 cycles of 95°C for 15 s and 60°C for 1 min. The primer pair used in these experiments recognized the neomycin phosphotransferase gene: forward 5Ј-CTTGCTCCTGCCGAGAAAGT-3Ј and reverse 5Ј-TTC GCTTGGTGGTCGAATG-3Ј. The probe sequence is 5Ј(FAM)-CAGCCGCCGCATTGCATCA-(TAMRA)-3Ј. FAM is the reporter dye used and TAMRA is the quencher. The Tm and GC% are shown in Table 1 and were developed using Primer Express 3.0 Software (PE Applied Biosystems). The amplicon is predicted to be 95 basepairs (as opposed to conventional PCR, the kinetics of this reaction favor smaller amplicons). To optimize the reaction we tested primer concentrations at 300/300 and 900/900 nm and each combination was tested with 100 and 200 nm of probe. Reaction kinetics were similar with all combinations and 100 nm probe with 300/300 nm of primers were chosen for subsequent reactions.
Serial dilution of vector supernatant was generated to evaluate the neo primer and probe combination and their ability to discriminate samples with varying vector concentrations. The MSCV.hgp91 vector, being produced in the Indiana University Vector Production Facility for Dr Mary Dinauer, contains the human gp91 phox gene and the neo gene and was selected because of its high titer (1 × 10 7 G418-resistant colony-forming units or c.f.u./ml). A standard amount of RNA (200 ng) were added to each reaction. Figure 1a shows the kinetics of the reaction with change in fluorescence (⌬R) on the y-axis and the cycle of PCR on the x-axis. Since the estimation of target sequence is related to the threshold cycle (the cycle where fluorescence first exceeds baseline), a plot of the threshold cycle at the various vector dilutions is shown in Figure 1b. A linear relationship was noted over the range tested (10 7 to 10 5 c.f.u./ml) with a correlation coefficient of 0.974. In addition, the overlap of dots at each timepoint shown in Figure 1b illustrates the close correlation of the triplicate samples tested at each dilution.
We next sought to determine if similar findings could be obtained if a standard volume was added to the reaction (as opposed to a standard RNA amount). The advantages of a standard volume are the ease of sample processing and decreased variability that might arise during optical density measurements. The identical samples used in Figure 1 were analyzed except that 3 l of the isolated RNA was added to each reaction. This volume is predicted to contain 600 ng, the vast majority of which is carrier RNA. A standard curve similar to that shown in Figure 1 was obtained (correlation coefficient 0.946, data not shown) using a standardized volume indicating that the isolation method described here provides con- To determine the utility of real-time PCR in determining vector titer, supernatant was obtained from a clinical vector production run of the MSCV.MGMT vector (produced for Dr David A Williams). The MSCV.MGMT vector contains the methylguanine methyltransferase gene and the neo gene and is amphotropically packaged in the GP+envAM12 cell line. 13 Vector was harvested sequentially from roller bottle cultures. A functional titer was determined, in triplicate, using the G418 resistance assay (described in Table 2 ). Triplicate PCR reactions were performed for each sample and compared with a standard curve derived from serial dilutions of the MSCV.hgp.91 vector. As shown in Table 2 , there is a close correlation between the biologically determined titer and the RT-PCR method. Since the biologic method requires 14 days and the PCR method can be performed and analyzed within 8 h, the PCR method greatly shortens the time required to determine titer.
The data presented above demonstrate the utility of our primers and probe at vector concentrations suitable for experimental and clinical work (ie high-titer vector). To increase the sensitivity of the assay method (ie lowtiter samples), we sought to identify the concentration of carrier which maximized RNA isolation. In addition, we sought to minimize the resuspension volume of precipitated RNA, thereby increasing the number of vector particles per reaction. Serial dilutions of MSCV.hgp91 were prepared and RNA was isolated from 300 l of supernatant with varying amounts of tRNA (1 g, 10 g or 20 g) added as carrier. After isopropanol precipitation, the RNA was resuspended in either 50, 100 or 500 l of RNase-free water and 10 l was added to each one-step RT-PCR reaction. As shown in Figure 2 , similar detection curves were noted over a large range of vector titers, suggesting considerable latitude is possible in selecting the concentration of carrier RNA. Since the concentration of carrier RNA did not affect detection, decreasing the resuspension volume from 500 to 50 l increases the number of vector particles per reaction 10-fold, thereby increasing the detection capabilities of the assay.
To maintain detection sensitivity, the manufacturer of the ABI Prism 7700 Sequence Detector recommends that the amount of RNA added to a one-step RT-PCR reaction be limited to 200 ng or less. Since concentrations of carrier RNA up to 2000 ng did not decrease the sensitivity of vector detection (Figure 2 ), we hypothesized that the relatively uniform nature of tRNA may decrease the amount of non-specific primer binding during PCR compared with total cellular RNA. To test this hypothesis, RNA was isolated from 300 l of MSCV.hgp91 supernate (titer 10 7 per ml) using 10 g of either yeast tRNA or total cellular RNA (isolated from the K562 leukemia cell line) as carrier. A one-step RT-PCR was performed as described above using decreasing amounts of the isolated RNA per reaction. As shown in Figure 3 , the use of total cellular RNA as carrier decreased the rate of sequence detection (additional cycles to rise above the threshold cycle) and the sensitivity of sequence detection (loss of detection at the lowest concentration). These findings suggest that tRNA is the preferred carrier RNA and can be used over a wide range of concentrations without significantly altering vector detection. The manufacturer's recommendations regarding the amount of RNA per reaction 
(a) Amplification plot of samples with each dilution represented in order from left to right on the graph. The x-axis represents the cycle of PCR. Only one of each triplicate samples per dilution is depicted for clarity. (b) Standard curve generated from amplification plot shown in (a). Each sample was performed in triplicate and is represented as a dot. Overlapping dots are present at most dilutions illustrating the tight correlation within each dilution. Correlation coefficient is 0.974. Triplicate tRNA controls were negative at 40 cycles of PCR.

Table 2 Comparison of biologic and PCR titer methods
Test article
G418 Titer PCR titer ×10 Values are titer ± standard deviation of the mean, all samples evaluated in triplicate. The G418 titer was determined by transducing 1 × 10 5 NIH3T3 cells with serial dilutions of vector (1 ml per culture) in the presence of polybrene (8 g/ml) for 2 h at 37°C, 5% CO 2 . G418 (800 g/ml) was added after 48 h and the titer was determined at 10 days at the dilution yielding 10-50 colonies per 60 mm plate. Cells were maintained in DMEM with 10% fetal calf serum. PCR samples were amplified in a one-step reaction using primers and probe for the neomycin phosphotransferase gene, as described in the text. appear prudent for total cellular RNA but can be exceeded when using tRNA. Based on the data obtained in Figures 2 and 3 , we use 10 g of tRNA to precipitate 300 l of supernatant and resuspend the dried RNA pellet in 100 l of RNAse-free water. Ten microliters of the RNA solution are added to a one-step RT-PCR reaction (1 g of RNA per reaction).
A major advantage of this method is the ability to identify rapidly high-titer clones which lack a selectable marker. We have used this method in the production of a Master Cell Bank using the GIPLII vector (generously provided by Cynthia Dunbar, NHLBI, NIH, Bethesda, MD, USA). G1PLII contains ATG-mutated neomycin phosphotransferase and ␤-galactosidase genes which does not produce protein and is intended as a marker vector. In the generation of such a Master Cell Bank, the G1PLII plasmid was introduced into the ecotropic packaging cell line GP+env86 14 by calcium phosphate transfection (Promega, Madison, WI, USA). Transient supernate was collected at 72 h and used to transduce the PG13 cell line 15 by the spinoculation technique described by Kotani and colleagues. 16 After 48 h, a single cell suspension of cells was sorted (Automatic Cell Deposition Unit fitted to the FACSstar Plus Cell Sorter, Becton Dickinson, San Jose, CA, USA) and individual cells were plated into 96-well dishes. Medium was obtained from confluent monolayers and assayed in triplicate for titer by RT-PCR using the probe and primers for the detection of the MSCV.hgp91 and MSCV.MGMT vectors described above. The real-time PCR threshold cycles for 85 clones are shown in Figure 4 . To establish that the supernatant data correlated with the vector production capacity of the clones, five clones with varying titer were expanded, grown to confluence in 75 cm 2 flasks and supernatant was collected 24 h after medium change. One milliliter of filtered (0.45 ) supernatant was used to transduce HELA cells (10 5 cells/60 mm 2 dish with polybrene, 10 g/ml for 2.5 h). Cells were collected after 48 h and DNA prepared using the Puregene Kit (Gentra Systems, Minneapolis, MN, USA) according to the manufacturer's cultured cell protocol. PCR was performed with 500 ng of DNA per reaction using the RT-PCR protocol described above, except for the deletion of reverse transcriptase and RNase inhibitor. As shown in Table 3 , the estimated vector RNA correlated with the relative DNA content of transduced HeLa cells. This confirms our hypothesis that PCR-based screening methods accurately predict the expected titer potential of producer cell clones. A Master Cell Bank was generated from the highest titer clone (clone 4) and used to generate clinical grade supernatant. The mean titer of this vector was 1.0 ± 0.26 (s.e.) × 10 6 from seven production harvests.
In summary, the method described above was rapid, required minimal amounts of material and was quantitative over a wide range of vector titers (between 10 1 and 10 6 vector particles per reaction). One concern with PCRbased titer methods is an inability to detect defective interfering particles or other inhibitors within the vector supernate. [17] [18] [19] Nevertheless, titer estimation reflected the biologic titers in this assay, suggesting the contribution of defective particles and inhibitors on titer is similar in the vectors tested in this study. We have noted this to be the case with vector produced in the GP+envAM12 cell line 13 and vector generated in the gibbon ape leukemia virus-derived producer cell line PG13. 15 The rapid turn around time of this method greatly facilitates isolation of high vector producer cell clones. When wells are confluent 300 l of medium can then be assayed. Suitable wells can then be expanded and analyzed further. Since the titer determination can be made within 8 h, passage of unsuitable clones is prevented saving significant technician time and materials. The method has helped us meet the challenge of identifying and evaluating vector producer cells without selectable trans- genes. Even for vectors with selectable markers, the case, reproducibility and speed with which this method can be performed has made it the preferred method of titer determination in our laboratory.
